[Form 4] CAMP4 Therapeutics Corporation Insider Trading Activity
Camp4 Therapeutics insider purchases reported by director and 10% owner Nashat Amir. On 09/11/2025 Polaris-affiliated entities purchased shares in a private placement at $1.53 per share under a Securities Purchase Agreement dated 09/09/2025. Purchases reported include 1,221,721 shares by Polaris Partners VII, L.P. and 85,468 shares by Polaris Entrepreneurs' Fund VII, L.P., with combined reported beneficial ownership following the transactions shown as 2,825,500 and 197,661 shares respectively and an additional 909,090 shares held indirectly by Polaris Partners X, L.P.
The filing discloses indirect ownership through management entities and contains standard disclaimers that the managing entities and reported persons disclaim beneficial ownership except to the extent of pecuniary interests.
- Material insider participation in a private placement at $1.53 per share, showing continued backing from Polaris-affiliated funds
- Clear disclosure of indirect ownership structures and post-transaction beneficial ownership amounts
- None.
Insights
TL;DR: Significant private placement purchases at $1.53 per share by Polaris funds increase Polaris-related stakes in CAMP.
The transactions show material purchases by Polaris-affiliated limited partnerships in a private placement priced at $1.53 per share pursuant to a Securities Purchase Agreement dated 09/09/2025. Reported direct ownership amounts and the post-transaction beneficial ownership figures indicate sizable positions held indirectly through fund GP structures. This type of Form 4 signals continued investor support from existing institutional backers rather than open-market trading and is relevant to cap table and control dynamics.
TL;DR: Disclosure details indirect ownership via GP entities and includes customary disclaimers of beneficial ownership.
The filing carefully maps ownership through general partner and managing-member relationships and includes disclaimers that the managing members and management entities disclaim beneficial ownership except for pecuniary interests. The report is consistent with standard Section 16 reporting for fund-held positions and clarifies the reporting person’s role as director and 10% owner through affiliated entities.